Cargando…
Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling
This study investigated the antitumor effects of foretinib on triple-negative breast cancer cells MDA-MB-231 xenograft tumors in vivo underlying phosphorylated mesenchymal to epithelial transition (p-MET)/ hepatocyte growth factor (HGF)-related mechanism, as well as its pharmacokinetic characteristi...
Autores principales: | Ji, Xiwei, Meng, Xiangrui, He, Qingfeng, Xiang, Xiaoqiang, Shi, Yufei, Zhu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821162/ https://www.ncbi.nlm.nih.gov/pubmed/36614199 http://dx.doi.org/10.3390/ijms24010757 |
Ejemplares similares
-
PRIMA-1(MET) Does Not Restore Vitamin
D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast
Cancer Cells
por: Kotob, Shadi N., et al.
Publicado: (2023) -
Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model
por: Huang, Zhaoming, et al.
Publicado: (2020) -
Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs
por: Ridolfi, E, et al.
Publicado: (2008) -
Inhibition of IGF signalling pathway in MDA-MB-231 triple negative breast cancer cells
por: Chandran, S, et al.
Publicado: (2012) -
Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231
por: Russo-Abrahão, Thais, et al.
Publicado: (2018)